China Portable Medical Equipment Industry Report, 2013-2016
  • Apr./2014
  • Hard Copy
  • USD $1,900
  • Pages:78
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZLC-002
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
      

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with market size growing at a CAGR of 28.3% in 2008-2013 to approximately RMB44.21 billion in 2013.

Allowing for the low penetration of portable medical devices (for example, market penetration of household glucometer is under 10% as opposed to the level of 90% in Europe, the United States and other developed countries), increasingly aging population, etc., China’s portable medical device market size is expected to remain above 25% growth rate in 2013-2016.

In China, portable medical devices are mainly used for home and clinical purposes, with market share of roughly 2:1 in 2013. Portable glucometer, electronic sphygmomanometer and electronic hearing aid as three hit products of China’s home-use portable medical device market accounted for a combined 93.6% in 2013.

Thus far, foreign-funded enterprises seize lion's share of China’s portable medical device market. Take household electronic sphygmomanometer and portable glucometer markets in 2013 for example, Japan-based OMRON accounted for more than 60% of China’s electronic sphygmomanometer market, followed by Andon Health, a domestic player whose market share was merely around 15%; America-based Johnson & Johnson and Switzerland-based Roche took 35% and 20% share of the Chinese portable glucometer market, separately, while the third and fourth-ranked domestic counterparts – Yicheng Bioelectronics and Sinocare only saw a combined share of 25%.

In China, clinical-use portable medical devices refer to portable multi-parameter monitor, portable diasonograph, portable electrocardiograph, interventional medical devices, portable fetal monitor, etc., of which, portable multi-parameter monitor and portable diasonograph occupy higher market share, respectively 32.5% and 25.0% of clinical-use portable medical device market in 2013.

2014050101.png

The report highlights the followings:
20120114.gif? Status quo, related polices, market share, competition pattern, trends, etc. of portable medical device industry in China;
20120114.gif? Status quo, competition pattern, etc. of Chinese home-use and clinical-use portable medical device product segments;
20120114.gif? Operation, development in China and forecast of 4 international and 8 domestic portable medical device enterprises;

1. Overview of Portable Medical Device

2. China Portable Medical Device Market 
2.1 Status Quo 
2.2 Related Policies 
2.3 Market Size
2.4 Trends 
2.4.1 Increasing Market Share of Domestic Enterprises
2.4.2 Emergence of Wearable Medical Devices
2.4.3 More Convenient and Extending Medical Service 
2.4.4 Promising Market 

3. Home-Use Portable Medical Devices in China 
3.1 Product Structure 
3.2 Electronic Sphygmomanometer
3.3 Portable Glucometer
3.4 Digital Hearing Aid 

4. Clinical-Use Portable Medical Devices in China 
4.1 Product Structure
4.2 Portable Multi-Parameter Monitor
4.3 Portable Diasonograph
4.4 Interventional Medical Devices
4.4.1 Insulin Pump
4.4.2 Implantable Cardiac Pacemaker
4.4.3 Capsule Endoscopy
4.5 Portable Electrocardiograph
4.6 Intelligent Infusion Pump

5. Leading Overseas Enterprises 
5.1 Johnson & Johnson
5.1.1 Profile 
5.1.2 Operation 
5.1.3 Portable Medical Device 
5.1.4 Development in China 
5.2 OMRON
5.2.1 Profile
5.2.2 Operation
5.2.3 Portable Medical Device
5.2.4 Development in China
5.3 A&D
5.3.1 Profile
5.3.2 Operation
5.3.3 Portable Medical Device
5.3.4 Development in China
5.4 Roche
5.4.1 Profile
5.4.2 Operation
5.4.3 Portable Medical Device
5.4.4 Development in China

6. Leading Chinese Enterprises 
6.1 Yu Yue Medical
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure 
6.1.4 Gross Margin 
6.1.5 R&D and Investment  
6.1.6 Prediction & Expectation 
6.2 Andon Health
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Prediction & Expectation
6.3 Sinocare
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Prediction & Expectation
6.4 Xiamen Comfort Science&Technology Group
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Portable Medical Device 
6.4.7 Prediction & Expectation
6.5 Guangdong Biolight Meditech
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 R&D and Investment
6.5.6 Prediction & Expectation
6.6 Mindray Medical International Limited
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 R&D and Investment
6.6.6 Portable Medical Device
6.6.7 Prediction & Expectation
6.7 Edan Instruments
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.5 R&D
6.7.6 Prediction & Expectation
6.8 Yicheng Bioelectronics
6.8.1 Profile 

7. Conclusion & Outlook 
7.1 Forecasting for China Portable Medical Device Market Size
7.2 Operating Contrast
7.2.1 Revenue 
7.2.2 Net Margin 
7.2.3 Gross Margin
7.2.4 R&D Input
Classification of Portable Medical Devices 
Population Ages 65 and Above % of Total in China, 2004-2013 
China Portable Medical Device Market Size, 2008-2013 
China Home-use Portable Medical Device Product Structure, 2013 
Advantages and Disadvantages of Different Sphygmomanometers
Competition Pattern of China Electronic Sphygmomanometer Market, 2013 
Five Stages of Technology Development for Blood Glucose Meter
Competition Pattern of China Portable Glucometer Market, 2013
China Clinical-Use Portable Medical Device Market Share by Variety, 2013 
Portable Multi-parameter Monitor
Global Insulin Pump Market Size, 2012-2017E 
Implantation Amount of Cardiac Pacemakers in China, 2006-2013 
Revenue and Net Income of Johnson & Johnson, 2009-2013 
Gross Margin of Johnson & Johnson, 2009-2013 
Subsidiaries in China
Net Sales and Net Income of OMRON, 2009-2012 
OMRON’s Net Sales in China and % of Total Sales, 2009-2012 
OMRON’s Net Sales in China by Department, 2009-2012 
Sales and Net Income of A&D, 2009-2013 
Sales and Net Income of Roche, 2009-2013
Development History of Roche in China 
Revenue and Net Income of Yu Yue Medical, 2009-2013 
Revenue Structure of Yu Yue Medical by Product, 2009-2013 
Revenue Structure of Yu Yue Medicalby Region, 2009-2013
Gross Margin of Yu Yue Medical, 2009-2013 
Gross Margin of Yu Yue Medical by Product, 2009-2013 
Gross Margin of Yu Yue Medical by Region, 2009-2013
R&D Input and % of Total Revenue of Yu Yue Medical, 2010-2013 
Revenue and Net Income of Yu Yue Medical, 2012-2016E
Revenue and Net Income of Andon Health, 2009-2013 
Revenue Structure of Andon Health by Product, 2009-2013 
Revenue Structure of Andon Health by Region, 2009-2013
Gross Margin of Andon Health, 2009-2013 
Gross Margin of Andon Health by Product, 2009-2013 
Gross Margin of Andon Health by Region, 2009-2013
Revenue and Net Income of Andon Health, 2012-2016E 
Revenue and Net Income of Sinocare, 2009-2013 
Revenue Structure of Sinocare by Region, 2009-2013 
Revenue Structure of Sinocare by Product, 2009-2013
Gross Margin of Sinocare, 2009-2013 
Gross Margin of Sinocare by Region, 2009-2013
Gross Margin of Sinocare by Product, 2009-2013
R&D Input and % of Total Revenue of Sinocare, 2010-2013
Revenue and Net Income of Sinocare, 2012-2016E
Revenue and Net Income of Xiamen Comfort Science&Technology Group, 2009-2013 
Revenue Structure of Xiamen Comfort Science&Technology Group by Region, 2009-2013 
Revenue Structure of Xiamen Comfort Science&Technology Group by Product, 2009-2013
Gross Margin of Xiamen Comfort Science&Technology Group, 2009-2013 
Gross Margin of Xiamen Comfort Science&Technology Group by Region, 2009-2013 
R&D Input and % of Total Revenue of Xiamen Comfort Science&Technology Group, 2010-2013
Revenue and Net Income of Xiamen Comfort Science&Technology Group, 2012-2016E
Revenue and Net Income of Guangdong Biolight Meditech, 2009-2013 
Revenue Structure of Guangdong Biolight Meditech by Product, 2009-2013
Revenue Structure of Guangdong Biolight Meditech by Region, 2009-2013
Gross Margin of Guangdong Biolight Meditech, 2009-2013 
Gross Margin of Guangdong Biolight Meditech by Product, 2009-2013
Gross Margin of Guangdong Biolight Meditech by Region, 2009-2013
R&D Input and % of Total Revenue of Guangdong Biolight Meditech, 2010-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2012-2016E
Revenue and Net Income of Mindray Medical International Limited, 2009-2013 
Revenue Structure of Mindray Medical International Limited by Product, 2009-2013
Revenue Structure of Mindray Medical International Limited by Region, 2009-2013
Gross Margin of Mindray Medical International Limited, 2009-2013 
R&D Input and % of Total Revenue of Mindray Medical International Limited, 2009-2013
Revenue and Net Income of Mindray Medical International Limited, 2012-2016E
Revenue and Net Income of Edan Instruments, 2009-2013 
Revenue Structure of Edan Instruments by Product, 2009-2013
Revenue Structure of Edan Instruments by Region, 2009-2013
Gross Margin of Edan Instruments, 2009-2013
Gross Margin of Edan Instruments by Product, 2009-2013 
R&D Input and % of Total Revenue of Edan Instruments, 2011-2013
Revenue and Net Income of Edan Instruments, 2012-2016E
China Portable Medical Device Market Size, 2012-2016E
Revenue of China’s Leading Portable Medical Device Enterprises, 2009-2013 
YoY Revenue Growth of China’s Leading Portable Medical Device Enterprises, 2010-2013 
Net Profit Margin of China’s Leading Portable Medical Device Enterprises, 2009-2013
Gross Margin of China’s Leading Portable Medical Device Enterprises, 2009-2013
R&D Input of China’s Leading Portable Medical Device Enterprises, 2010-2013
R&D Input and % of Total Revenue of China’s Leading Portable Medical Device Enterprises, 2010-2013

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号